“…Enzymatic Hydrolysis of 1, 3 and 4 to 1a, 1b and 1c, 3a, 3b and 3c, and 4a, 4b and 4c, Respectively Ebenamarioside A (1) (9.8 mg) in 1 mL of H 2 O hydrolyzed with 15 mg of crude glucosidase at 37°C for 72 h. The reaction mixture was subjected to silica gel CC (Φ = 2 cm, L = 15 cm) with increasing amounts of MeOH in CHCl 3 [CHCl 3 -MeOH (9 : 1, 50 mL), (9 : 1, 100 mL to 7 : 3, 100 mL, linear gradient), (7 : 3, 50 mL) and (1 : 1, 100 mL)], 10-mL fractions being collected. An aglycone (1c) (2.8 mg) was obtained in fractions 5-6 and the monosaccharide mixture (1a and 1b) (5.5 mg) in 10,11) Ebenamarioside C (3) (9.5 mg) in 1 mL of H 2 O was hydrolyzed with crude naringinase (15 mg) at 37°C for 72 h. The reaction mixture was subjected silica gel CC (Φ = 2 cm, L = 15 cm) with increasing amounts of MeOH in CHCl 3 [CHCl 3 -MeOH (9 : 1, 50 mL), (9 : 1, 100 mL to 7 : 3, 100 mL, linear gradient), (7 : 3, 50 mL) and (1 : 1, 100 mL) (5 × 10 3 cells/well) in 100 µL medium were added to each well, and then the plate incubated at 37°C under a 5% CO 2 atmosphere for 72 h. A solution (100 µL) of MTT (0.5 mg/mL) was then added to each well and the incubation was continued for a further 1 h. The absorbance of each well was measured at 540 nm using a Molecular Devices Versamax tunable microplate reader. DMSO was used as a negative control and doxorubicin as a positive control.…”